These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1171 related articles for article (PubMed ID: 24128118)

  • 41. Molecular characterization of
    Elegail A; Ibrahim Mohamed NY; Mohamed Nour EO; Hoffner S; Haile M
    Int J Mycobacteriol; 2018; 7(3):236-241. PubMed ID: 30198502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study.
    Li Q; Ou XC; Pang Y; Xia H; Huang HR; Zhao B; Wang SF; Zhao YL
    Tuberculosis (Edinb); 2017 Jul; 105():9-12. PubMed ID: 28610793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.
    de Vos M; Derendinger B; Dolby T; Simpson J; van Helden PD; Rice JE; Wangh LJ; Theron G; Warren RM
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: phenotypic and genotypic methods.
    Miyata M; Pavan FR; Sato DN; Marino LB; Hirata MH; Cardoso RF; de Melo FA; Zanelli CF; Leite CQ
    Biomed Pharmacother; 2011 Sep; 65(6):456-9. PubMed ID: 21880463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.
    Anthwal D; Gupta RK; Bhalla M; Bhatnagar S; Tyagi JS; Haldar S
    J Clin Microbiol; 2017 Jun; 55(6):1755-1766. PubMed ID: 28330890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand.
    Anek-Vorapong R; Sinthuwattanawibool C; Podewils LJ; McCarthy K; Ngamlert K; Promsarin B; Varma JK
    BMC Infect Dis; 2010 May; 10():123. PubMed ID: 20487550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid molecular detection of tuberculosis and rifampin resistance.
    Boehme CC; Nabeta P; Hillemann D; Nicol MP; Shenai S; Krapp F; Allen J; Tahirli R; Blakemore R; Rustomjee R; Milovic A; Jones M; O'Brien SM; Persing DH; Ruesch-Gerdes S; Gotuzzo E; Rodrigues C; Alland D; Perkins MD
    N Engl J Med; 2010 Sep; 363(11):1005-15. PubMed ID: 20825313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
    Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
    Sharma S; Madan M; Agrawal C; Asthana AK
    Indian J Pathol Microbiol; 2014; 57(3):423-6. PubMed ID: 25118735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.
    Chumpa N; Kawkitinarong K; Rotcheewaphan S; Sawatpanich A; Petsong S; Tumwasorn S; Suwanpimolkul G
    Mol Biol Rep; 2020 Apr; 47(4):2501-2508. PubMed ID: 32124172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR.
    Bang H; Park S; Hwang J; Jin H; Cho E; Kim DY; Song T; Shamputa IC; Via LE; Barry CE; Cho SN; Lee H
    J Med Microbiol; 2011 Oct; 60(Pt 10):1447-1454. PubMed ID: 21596910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices.
    Gomgnimbou MK; Hernández-Neuta I; Panaiotov S; Bachiyska E; Palomino JC; Martin A; del Portillo P; Refregier G; Sola C
    J Clin Microbiol; 2013 Nov; 51(11):3527-34. PubMed ID: 23966495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of multidrug-resistance in Mycobacterium tuberculosis by phenotype- and molecular-based assays.
    Vasiliauskaitė L; Bakuła Z; Vasiliauskienė E; Bakonytė D; Decewicz P; Dziurzyński M; Proboszcz M; Davidavičienė EV; Nakčerienė B; Krenke R; Kačergius T; Stakėnas P; Jagielski T
    Ann Clin Microbiol Antimicrob; 2024 Aug; 23(1):81. PubMed ID: 39198827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid.
    Shah M; Paradis S; Betz J; Beylis N; Bharadwaj R; Caceres T; Gotuzzo E; Joloba M; Mave V; Nakiyingi L; Nicol MP; Pradhan N; King B; Armstrong D; Knecht D; Maus CE; Cooper CK; Dorman SE; Manabe YC
    Clin Infect Dis; 2020 Aug; 71(5):1161-1167. PubMed ID: 31560049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergy of Xpert (MTB/RIF) and Line probe assay for detection of rifampicin resistant strains of Mycobacterium tuberculosis.
    Hussain S; Sultan S; Riaz S; Hussain H; Javed H; Mazhar R
    J Infect Dev Ctries; 2024 Aug; 18(8):1241-1248. PubMed ID: 39288387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea.
    Cho EH; Bae HK; Kang SK; Lee EH
    Korean J Lab Med; 2009 Oct; 29(5):455-60. PubMed ID: 19893355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
    Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
    PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.